🔴 Website 👉 https://u-s-news.com/
Telegram 👉 https://t.me/usnewscom_channel
The American Lookout Headlines homepage has 60 new headlines every 24 hours – click here to see it.
Roche, a swiss pharmaceutical giant will invest billions of dollars into the United States over the next five years.
Swiss pharmaceutical giant Roche announced Tuesday it will invest upwards of $50 billion in the United States over the next five years, a move that follows in the wake of President Donald Trump’s announcement of proposed tariffs on imported drugs.
The U.S. is a critical market for the pharmaceutical industry, representing more than half of the revenue of Roche’s pharmaceutical division, AFP reports.
Roche said, “These investments further strengthen Roche’s already significant US footprint with 13 manufacturing and 15 R&D sites across the Pharmaceutical and Diagnostics Divisions, and are expected to create more than 12,000 new jobs, including nearly 6,500 construction jobs, as well as 1,000 jobs at new and expanded facilities.”
Expanded and upgraded US manufacturing and distribution capabilities for its innovative medicines and diagnostics portfolio in Kentucky, Indiana, New Jersey, Oregon and California
A state-of-the-art gene therapy manufacturing facility in Pennsylvania
A new 900,000 square foot manufacturing centre to support Roche’s expanding portfolio of next generation weight loss medicines (location to be announced)
A new manufacturing facility for continuous glucose monitoring in Indiana
A new R&D centre in Massachusetts, conducting cutting-edge artificial intelligence (AI) research and serving as hub for our new cardiovascular, renal and metabolism research and development efforts
Significant expansion and upgrading of our existing pharmaceuticals and diagnostics R&D centres in Arizona, Indiana and California
Another win for Trump!